Stock Titan Trading tools for traders and investors.

-

10:27:06 AM

Last BNTX Stock Market News

BNTX - BioNTech SE

11/09/20 6:45 AM

Nasdaq : BNTX

Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study

Vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis Analysis evaluated 94 confirmed cases of COVID-19 in trial participants Study enrolled 43,538 participants, with 42%

RHEA-AI

neutral

11/03/20 9:00 AM

Nasdaq : BNTX

BioNTech to Report Third Quarter 2020 Financial Results and Operational Update on November 10, 2020

Mainz, Germany, November 3, 2020 - BioNTech SE (Nasdaq: BNTX, "BioNTech" or "the Company") will announce its financial results for the third quarter 2020 on Tuesday, November 10 th, 2020. BioNTech invites investors and the general public to join a conference call and webcast with

RHEA-AI

neutral

10/14/20 5:00 PM

Nasdaq : BNTX

BioNTech to Present Data from BNT311 (GEN1046) and BNT131 (SAR441000) Programs at SITC 35th Annual Meeting

Data updates from key oncology collaborations to be presented Preliminary data from the first-in-human trial from intratumoral immunotherapy program BNT131 (SAR441000) in collaboration with Sanofi, to be presented in an e-poster Preliminary Phase 1/2 and preclinical data of DuoBody(R)-PD-L1x4-1BB,

RHEA-AI

very positive

10/06/20 5:01 AM

Nasdaq : BNTX

BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2

Rolling review accepted by the EMA based on available preclinical and clinical data for BNT162b2 to date BioNTech and Pfizer will continue regular and open dialogue with the EMA providing results from their ongoing Phase 3 study NEW YORK and MAINZ, GERMANY, October 6 , 2020 -- Pfizer Inc. (NYSE:

RHEA-AI

neutral

09/17/20 4:00 AM

Nasdaq : BNTX

BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First Half 2021

Facility will become one of the largest mRNA manufacturing sites in Europe and the third site in the BioNTech manufacturing network in Germany expected to produce BNT162 for global supply Expected to be fully operational in the first half 2021

RHEA-AI

very positive

09/15/20 6:30 AM

Nasdaq : BNTX

BioNTech to Receive up to EUR375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162

The German Federal Ministry of Education and Research (BMBF) COVID-19 initiative supports accelerated vaccine development, as well as upscaling of manufacturing capabilities in Germany Five out of eight milestones defined in the BMBF funding for

RHEA-AI

very positive

09/12/20 11:17 AM

Nasdaq : BNTX

Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial

NEW YORK and MAINZ, GERMANY, September 12 -- Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) announced today that they have submitted an amended protocol to the U.S. Food and Drug Administration to expand the enrollment of

RHEA-AI

neutral

09/09/20 7:45 AM

Nasdaq : BNTX

Pfizer and BioNTech Announce Data From Preclinical Studies of mRNA-Based Vaccine Candidate Against COVID-19

Immunization of non-human primates (rhesus macaques) with BNT162b2, a nucleoside-modified messenger RNA (modRNA) candidate that expresses the SARS-CoV-2 spike glycoprotein, resulted in strong anti-viral effects against an infectious SARS-CoV-2 challenge BNT162b2 immunization prevented lung

RHEA-AI

neutral

09/09/20 6:15 AM

Nasdaq : BNTX

Pfizer and BioNTech to Potentially Supply the EU with 200 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2

The proposed agreement is intended to provide a supply of 200 million doses and an option to purchase additional 100 million doses, with deliveries starting by the end of 2020, subject to regulatory approval The vaccine supply for the EU would be produced by BioNTech's manufacturing sites in

RHEA-AI

very positive

09/08/20 6:30 AM

Nasdaq : BNTX

Biopharma Leaders Unite to Stand with Science

The CEOs of AstraZeneca (LSE/STO/NYSE: AZN), BioNTech SE (NASDAQ: BNTX),

RHEA-AI

neutral

Prev 1 2 3 4 5 6 7 8 Next